s-1-(combination) and Soft-Tissue-Neoplasms

s-1-(combination) has been researched along with Soft-Tissue-Neoplasms* in 1 studies

1 other study(ies) available for s-1-(combination) and Soft-Tissue-Neoplasms

Article	Year
Efficacy of Anlotinib combined with S-1 as the second-line treatment for advanced soft tissue sarcoma. Asian journal of surgery, 2023, Volume: 46, Issue:2 Topics: Humans; Indoles; Quinolines; Sarcoma; Soft Tissue Neoplasms	2023